🏛 Organisation

REVIVE-TOGETHER

1 story First seen Jul 19, 2026 Latest Jul 19, 2026

🧬 AI profile — grown from 6ic coverage REVIVE-TOGETHER is a collaborative research initiative focused on developing and implementing effective treatments for COVID-19 and its long-term effects. Led by researchers and clinicians from institutions worldwide, the organization has been instrumental in advancing our understanding of Long COVID and identifying potential therapeutic options. REVIVE-TOGETHER's work has contributed to the recent breakthrough involving fluvoxamine, an antidepressant medication that shows promise in reducing fatigue associated with Long COVID.

Coverage by desk

Science 1

Coverage · last 14 days

Jul 7Jul 20

Recurring themes

long COVID ×1 fluvoxamine ×1 McMaster University ×1 Brazil ×1 clinical trial ×1

🕸 Connection map 🌌 Full galaxy →

Connected entities

Fluvoxamine ×1 Brazilian ×1 Stanford University ×1 Metformin ×1 McMaster University ×1 Brazil ×1 COVID ×1 University of British Columbia ×1 SARS-CoV-2 ×1

Every story (1)

Breakthrough in Long COVID Treatment: Fluvoxamine Shows Promise in Reducing Fatigue

Science · Jul 19, 2026 · BlockchainSpace AI